Workflow
Wuhan Citms Technology (688038)
icon
Search documents
中科通达(688038) - 关于终止发行股份及支付现金购买资产并募集配套资金暨关联交易事项的公告
2025-09-19 09:15
证券代码:688038 证券简称:中科通达 公告编号:2025-044 武汉中科通达高新技术股份有限公司 关于终止发行股份及支付现金购买资产并募集配套资金 暨关联交易事项的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 武汉中科通达高新技术股份有限公司(以下简称"公司")于 2025 年 9 月 19 日分别召开第五届董事会第十一次会议、第五届监事会第八次会议,审议通 过了《关于终止发行股份及支付现金购买资产并募集配套资金暨关联交易事项的 议案》和《关于公司与交易对方签署终止协议的议案》,同意公司终止本次发行 股份及支付现金购买资产并募集配套资金暨关联交易事项,以及与交易对方签署 相关终止协议,并授权公司管理层办理终止本次交易相关事宜,现就有关情况公 告如下: 一、本次交易的基本情况 公司拟通过发行股份及支付现金的方式购买深圳星和动力科技有限公司(以 下简称"交易对方")持有的星和动力(北海)科技有限公司 100%股权,同时 向不超过 35 名符合条件的特定投资者发行股份募集配套资金(以下简称"本次 交易")。本次交 ...
中科通达(688038) - 第五届监事会第八次会议决议公告
2025-09-19 09:15
证券代码:688038 证券简称:中科通达 公告编号:2025-043 武汉中科通达高新技术股份有限公司 第五届监事会第八次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 武汉中科通达高新技术股份有限公司(以下简称"公司")第五届监事会第 八次会议于 2025 年 9 月 19 日以通讯方式召开,会议通知于 2025 年 9 月 14 日以 电子邮件方式送达全体监事。本次会议应出席的监事 3 人,实际出席会议的监事 3 人,符合《公司章程》要求的法定人数。本次会议的召开符合法律、行政法规、 部门规章、规范性文件和公司章程的有关规定。本次会议由监事会主席李严圆女 士主持。 表决结果:3 票同意,0 票反对,0 票弃权。 特此公告。 1.审议《关于终止发行股份及支付现金购买资产并募集配套资金暨关联交 易事项的议案》 经审议,监事会认为公司本次终止发行股份及支付现金购买资产并募集配套 资金暨关联交易事项符合相关法律、行政法规和中国证监会的规定,审批程序合 法,不会对公司日常经营和未来发展造成重大不利影响,不存在损害 ...
中科通达(688038) - 第五届董事会第十一次会议决议公告
2025-09-19 09:15
证券代码:688038 证券简称:中科通达 公告编号:2025-042 武汉中科通达高新技术股份有限公司 第五届董事会第十一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 武汉中科通达高新技术股份有限公司(以下简称"公司")第五届董事会第 十一次会议于 2025 年 9 月 19 日以通讯方式召开。会议通知于 2025 年 9 月 14 日 以电子邮件方式送达全体董事、监事。应出席会议的董事 9 人,实际出席会议的 董事 9 人,符合《公司章程》要求的法定人数。本次会议的召开符合法律、行政 法规、部门规章、规范性文件和公司章程的有关规定。本次会议由公司董事长王 开学先生主持。 表决结果:9 票同意,0 票反对,0 票弃权。 本议案已经公司第五届董事会独立董事专门会议第三次会议、第五届董事会 审计委员会第八次会议、第五届董事会战略委员会第五次会议审议通过。 具体内容详见公司同日在上海证券交易所网站(www.sse.com.cn)披露的《关 于终止发行股份及支付现金购买资产并募集配套资金暨关联交易事项的公告》 ...
中科通达终止增发收购相关事项
Zhi Tong Cai Jing· 2025-09-19 08:57
Core Viewpoint - The company has decided to terminate the issuance of shares and cash payment for asset acquisition, along with the related fundraising and associated transactions [1] Group 1 - The company's board and supervisory board have approved the termination of the asset acquisition and fundraising transaction [1] - The company will sign a termination agreement with the transaction counterparties [1] - The management has been authorized to handle all matters related to the termination of this transaction [1]
中科通达(688038.SH)终止增发收购相关事项
智通财经网· 2025-09-19 08:56
智通财经APP讯,中科通达(688038.SH)公告,公司董事会、监事会审议通过了《关于终止发行股份及 支付现金购买资产并募集配套资金暨关联交易事项的议案》和《关于公司与交易对方签署终止协议的议 案》,同意公司终止本次发行股份及支付现金购买资产并募集配套资金暨关联交易事项,以及与交易对 方签署相关终止协议,并授权公司管理层办理终止本次交易相关事宜。 ...
中科通达:终止发行股份及支付现金购买资产并募集配套资金
Xin Lang Cai Jing· 2025-09-19 08:53
Core Viewpoint - The company announced the termination of the asset acquisition and fundraising plan due to failure to reach agreement on key terms with the counterparty, prioritizing the interests of the company and its shareholders [1] Group 1 - The company will hold a board and supervisory committee meeting on September 19, 2025, to review the decision to terminate the acquisition of 100% equity in Xinghe Power (Beihai) Technology Co., Ltd. from Shenzhen Xinghe Power Technology Co., Ltd. [1] - The company planned to raise matching funds by issuing shares to no more than 35 specific investors as part of the transaction [1] - The company has committed not to plan any major asset restructuring matters for at least one month from the date of the announcement [1]
中科通达连亏三年半 2021年上市即巅峰国泰海通保荐
Zhong Guo Jing Ji Wang· 2025-09-18 06:55
Core Viewpoint - Zhongke Tongda (688038.SH) reported a significant decline in revenue and net profit for the first half of 2025, indicating ongoing financial challenges for the company [1] Financial Performance - The company achieved operating revenue of 82.88 million yuan, a year-on-year decrease of 51.96% [1] - The net profit attributable to shareholders was -849,800 yuan, a year-on-year decrease of 112.14% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -1.98 million yuan, a year-on-year decrease of 130.87% [1] - The net cash flow from operating activities was 29.49 million yuan, compared to -48.58 million yuan in the same period last year [1] Historical Financial Data - The net profit attributable to shareholders for the years 2022, 2023, and 2024 were -8.44 million yuan, -103 million yuan, and -18.10 million yuan respectively [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses for the same years were -19.33 million yuan, -108 million yuan, and -19.69 million yuan respectively [1] IPO and Fundraising - Zhongke Tongda was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on July 13, 2021, with an issuance of 29.09 million shares at a price of 8.60 yuan per share [1] - The total amount raised during the IPO was 250 million yuan, with a net amount of 199 million yuan after deducting issuance costs, which was 181 million yuan less than the original plan of 380 million yuan [2] - The total issuance costs amounted to 51.19 million yuan, with Haitong Securities receiving 32.47 million yuan as underwriting fees [2]
10只股中线走稳 站上半年线
Core Viewpoint - The A-share market shows a mixed performance with the Shanghai Composite Index closing at 3820.98 points, slightly below the previous close, and a total trading volume of 1.472 trillion yuan, indicating a cautious market sentiment [1] Group 1: Market Performance - The Shanghai Composite Index closed at 3820.98 points, with a decline of 0.96% [1] - The total trading volume in the A-share market reached 1.472 trillion yuan [1] Group 2: Stocks Breaking Half-Year Line - A total of 10 A-shares have surpassed the half-year line today, with notable stocks including Renfu Pharmaceutical, Guofeng New Materials, and *ST Sihuan showing significant deviation rates of 8.65%, 6.97%, and 3.30% respectively [1] - Stocks with smaller deviation rates that just crossed the half-year line include Yiatong, Sifang Co., and Meike Home, indicating a more cautious upward movement [1] Group 3: Individual Stock Performance - Renfu Pharmaceutical (600079) saw a price increase of 9.99% with a turnover rate of 7.60%, closing at 22.57 yuan, with a deviation rate of 8.65% from the half-year line [1] - Guofeng New Materials (000859) increased by 8.22% with a turnover rate of 8.12%, closing at 7.24 yuan, showing a deviation rate of 6.97% [1] - *ST Sihuan (000518) rose by 3.46% with a turnover rate of 2.24%, closing at 2.39 yuan, with a deviation rate of 3.30% [1]
中科通达: 股东集中竞价减持股份计划公告
Zheng Quan Zhi Xing· 2025-08-29 17:46
Group 1 - The major shareholders of Wuhan Zhongke Tongda High-tech Co., Ltd. include Wuhan Gaoke State-owned Holding Group Co., Ltd. holding 5 million shares (4.30%) and Wuhan Optics Valley Growth Venture Capital Fund Co., Ltd. holding 10 million shares (8.59%), totaling 15 million shares (12.89%) [1][2] - Wuhan Gaoke plans to reduce its holdings through centralized bidding, with a maximum reduction of 1,163,700 shares (1.00%) from September 19, 2025, to December 18, 2025 [3][4] - The reduction is due to the operational needs of Wuhan Gaoke, and the shares to be reduced were acquired before the company's IPO [3][4] Group 2 - The reduction plan will be adjusted if there are any corporate actions such as dividends, stock splits, or capital increases during the reduction period [2] - The shareholders have not reduced their holdings since the company went public [2][4] - The reduction plan complies with relevant laws and regulations, and there are no circumstances that prohibit the reduction of shares [5]
8月28日增减持汇总:暂无增持,上纬新材等21股减持(表)
Xin Lang Zheng Quan· 2025-08-28 13:23
Core Viewpoint - As of August 28, no listed companies have disclosed any increase in shareholding, while 21 companies have announced share reductions by their shareholders [1]. Summary by Category Share Reduction Announcements - Keg Precision Machinery: Controlling shareholder plans to reduce holdings by up to 3% [2] - Oulu Tong: Controlling shareholder and actual controller's concerted action party plans to reduce holdings by up to 1.74% [2] - Nanmo Biology: Plans to reduce repurchased shares by up to 1% of total share capital [2] - Weike Technology: Three shareholders plan to transfer a total of 2.99% of total share capital [2] - Jino Medical: Shareholder plans to reduce holdings by up to 0.04% [2] - Zhejiang Shiyu: Controlling shareholder plans to reduce holdings by up to 2% [2] - Zhongke Tongda: Shareholder Wuhan Gaoke plans to reduce holdings by up to 1% [2] - Chunzong Technology: Multiple shareholders plan to reduce holdings by up to 2% [2] - Wantong Expressway: Shareholder China Merchants Highway plans to reduce holdings by up to 3% [2] - Tai Rui Machinery: Actual controller Zheng Jianguo plans to reduce holdings by up to 2.95% [2] - Haotong Technology: Actual controller Xia Jun and specific shareholder Xuzhou Botong plan to reduce holdings by up to 3% [2] - Changsheng Bearing: Some senior management plans to reduce holdings by up to 1.2% [2] - Dongtian Micro: Shareholder plans to reduce holdings by up to 0.57% [2] - Aojie Technology: Shareholder Ali Network plans to reduce holdings by up to 3% [2] - Bocheng Shares: Some directors and senior management plan to reduce holdings [2] - Rongtai Shares: Shareholder Tai'an Runtu plans to reduce holdings by up to 1.05% [2] - Shangwei New Materials: Jinfeng Investment Holdings has completed the reduction of 4.0336 million shares [2] - Zhongchu Logistics: Senior management member Chu Xuri plans to reduce holdings by up to 0.09% [2] - Hengsheng Energy: One of the actual controllers, Gan Shunxian, plans to reduce holdings by up to 2% [2] - Jinghua New Materials: Controlling shareholder plans to reduce holdings by up to 3.01% [2] - New Coordinates: Shareholder plans to reduce holdings by up to 1% [2]